e Laboratories (US:CLB) ZACKS·2024-07-24 23:10Core Laboratories Overview - Core Laboratories reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.21 per share, and matching earnings from the previous year [8] - The company posted revenues of $130.58 million for the quarter ended June 2024, which was 1.33% below the Zacks Consensus Estimate, but an increase from $127.88 million year-over-year [2] - Core Laboratories has surpassed consensus EPS estimates two times over the last four quarters [9] Stock Performance - Core Laboratories shares have increased approximately 26.1% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] - The stock's immediate price movement will depend on management's commentary during the earnings call and future earnings expectations [10] Future Earnings Expectations - The current consensus EPS estimate for the upcoming quarter is $0.26 on revenues of $136.15 million, and for the current fiscal year, it is $0.94 on revenues of $537.13 million [5] - The estimate revisions trend for Core Laboratories is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [12] Industry Context - The Oil and Gas - Field Services industry, to which Core Laboratories belongs, is currently ranked in the bottom 13% of over 250 Zacks industries, which may impact stock performance [13] - Another company in the same industry, Archrock Inc., is expected to report revenues of $270.59 million, reflecting a 9.3% increase from the previous year [7]